- ►unair.ac.id [PDF] RG Naik, JP Palmer - Reviews in Endocrine & Metabolic Disorders, 2003 - Springer A very large amount of clinical and basic research sup- ports our current
understanding that there are two major types of diabetes, termed type 1 diabetes
(T1DM) (previ- ously known as insulin-dependent diabetes, IDDM) and type 2 ... Cited by 32 - Related articles - BL Direct - All 8 versions
- ►diabetesjournals.org C Tiberti, C Giordano, M Locatelli, E Bosi, GF … - Diabetes, 2008 - Am Diabetes Assoc RESULTS—IA-2 (256–760) fragment was identified as the marker with the
highest sensitivity for detection of humoral IA-2 immunoreactivity in LADA
patients, identifying IA-2 autoantibodies in ∼30% of GAD antibody (GADA)- ... Cited by 6 - Related articles - BL Direct - All 4 versions
J Seissler - Current Diabetes Reports, 2008 - Springer About 10% of patients with the clinical presentation of type 2 diabetes suffer
from an autoimmune form of dia- betes associated with a rapid decline of
residual -cell mass and subsequent development of insulin depen- dency. In ... Cited by 4 - Related articles - BL Direct - All 2 versions
- ►ufjf.br [PDF] B Brooks-Worrell, A Warsen, JP Palmer - Journal of Immunological Methods, 2009 - Elsevier Diabetes mellitus is comprised primarily of two clinically separate diseases:
type 1 (T1D) and type 2 diabetes (T2D). T1D is a cell-mediated autoimmune
disease directed against the beta cells and characterized by autoantibody ... Cited by 1 - Related articles - All 3 versions
M Shioya, A Andoh, S Kakinoki, A Nishida, Y … - Pancreas, 2008 - journals.lww.com Objectives: Interleukin (IL) 22 is a recently identified T-cellYderived
cytokine. IL-22 binds at the cell surface to a heterodimer receptor complex
composed of IL-22 receptor (R) 1 and IL-10R2. In this study, we performed ... Related articles - BL Direct - All 2 versions